What we're reading, November 23, 2016: Alaska has a novel plan to hold down insurance premiums; MedPAC's executive director discusses continuation of value efforts; and new findings regarding microcephaly in Zika-infected babies.
Alaska is going to pay for the healthcare costs of the 500 sickest patients in the state in order to hold down premiums for the rest of the state’s residents. According to The Wall Street Journal, the sickest patients in the state had contributed to health insurance premiums rising 40% for the entire state. Now, Alaska, which is controlled by a Republican legislature, will contribute $55 million for at least 1 year to cover the costs of those patients.
During a Bloomberg Government discussion, the executive director of the Medicare Payment Advisory Commission (MedPAC) discussed efforts to bring more value to Medicare. He discussed increasing the adoption of site-neutral payments across Medicare and the expansion of bundled payments in fee-for-service, reported Bloomberg.
The abnormally small heads that became a way of identifying babies affected by the Zika virus may not be a reliable way to determine babies with microcephaly. Data has shown that a small group of babies born in Brazil who were infected with the Zika virus were born with normal sized heads, but developed microcephaly 5 months after being born, according to The Washington Post. Even without microcephaly, the Zika-infected babies had brain abnormalities, such as severe neurological damage.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More